作者:Ocuphire Pharma(RNN)
发布于: | 公告 | 转发:0 | 回复:0 | 喜欢:0 |
$Rexahn Pharmaceuticals, Inc.(RNN)$ 8-K - Current report Filed: 2018-10-19 AccNo: 0001140361-18-040906 Size: 613 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接